Showing results (91-100 of 152) with videos related to

Sort By:
Pageof 16
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 17, 2023
Polyphotosensitizer-Based Nanoparticles with Michael Addition Acceptors Inhibiting GST Activity and Cisplatin Deactivation for Enhanced Chemotherapy and Photodynamic ImmunotherapyQinxin Zhao, Ganghao Liang, Boda Guo, et al.
Oncology Letters|May 8, 2018
Expression of CD74 in bladder cancer and its suppression in association with cancer proliferation, invasion and angiogenesis in HT-1376 cellsJun-Wei Gai, Wasilijiang Wahafu, Liming Song, et al.
Indian Journal of Cancer|March 2, 2023
Application of laparoscopic ultrasound in retroperitoneal radical nephrectomy for renal cell carcinoma with Type II inferior vena cava tumor thrombectomyWen Cao, Shijun Mi, Zexing Yu, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 21, 2025
PSMA-Targeted Nanoparticles with PI3K/mTOR Dual Inhibitor Downregulate P-Glycoprotein and Inactivate Myeloid-Derived Suppressor Cells for Enhanced Chemotherapy and Immunotherapy in Prostate CancerLu Yin, Feiya Yang, Wenkuan Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 20, 2024
High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumorFangming Wang, Gang Zhang, Tianli Xu, et al.
Scientific Reports|May 10, 2025
The impact of radiotherapy on the prognosis of metastatic clear cell renal cell carcinoma after surgeryXuwen Li, Zhongyu Tan, Yihao Zhu, et al.
Discover Oncology|September 3, 2025
Identification and verification of exosome-related gene signature to predict the cancer status and prognosis of prostate cancerHaoxi Wang, Xuwen Li, Liyuan Wu, et al.
Future Oncology (London, England)|October 12, 2023
siRNA-based approaches for castration-resistant prostate cancer therapy targeting the androgen receptor signaling pathwayYanling Yu, Dimitri Papukashvili, Ruimin Ren, et al.
Nature Communications|February 14, 2019
Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancerSong Wu, Tong Ou, Nianzeng Xing, et al.
Frontiers in Oncology|August 29, 2022
Evaluation and multi-institutional validation of a novel urine biomarker lncRNA546 to improve the diagnostic specificity of prostate cancer in PSA gray-zoneFei Liu, Xiaolei Shi, Fangming Wang, et al.
Pageof 16